Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection
Ramesh K. Goyal(Delhi Pharmaceutical Science and Research University), Subbu Apparsundaram(Vanderbilt University Medical Center), Jaseela Majeed(Delhi Pharmaceutical Science and Research University), Mahaveer Dhobi(Delhi Pharmaceutical Science and Research University), Kalicharan Sharma(Indo Soviet Friendship College of Pharmacy), Bhoomika M. Patel(Suamandeep Vidyapeeth University), Rajiv Kumar Tonk(Delhi Pharmaceutical Science and Research University)
Cited by 26
Related Papers
Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies
|Journal of Autoimmunity|2021|234
Quinoline‐derivatives as privileged scaffolds for medicinal and pharmaceutical chemists: A comprehensive review
|Chemical Biology & Drug Design|2022|92
Ganoderic acid loaded nano-lipidic carriers improvise treatment of hepatocellular carcinoma
|Drug Delivery|2019|85
Therapeutic opportunities of edible antiviral plants for COVID-19
|Molecular and Cellular Biochemistry|2021|63